INIS
patients
100%
liver
46%
diseases
33%
evaluation
28%
therapy
27%
malignancies
22%
ulcers
17%
hospitals
17%
symptoms
16%
variations
15%
injuries
15%
cytology
13%
women
12%
inflammation
12%
esophagus
12%
stomach
11%
jaundice
11%
biopsy
10%
bile
10%
india
10%
genes
9%
cancer
9%
abscesses
9%
rectum
9%
calculi
9%
management
9%
colon
8%
tissues
8%
mortality
8%
control
8%
quality of life
8%
risks
7%
diet
7%
guidelines
7%
ph value
7%
granulomas
7%
utilities
7%
cysts
7%
pathology
7%
proteins
7%
images
7%
pneumatics
7%
inhibition
7%
diaphragm
7%
pancreas
7%
throat
7%
diabetes mellitus
7%
streptococcus
7%
lactobacillus
7%
saliva
7%
oral cavity
7%
defects
7%
salmonella
7%
kidneys
7%
biliary tract
7%
maintenance
7%
values
7%
sensitivity
7%
carcinomas
5%
uranium carbides
5%
comparative evaluations
5%
data
5%
losses
5%
hemorrhage
5%
hepatomas
5%
Medicine and Dentistry
Cancer
22%
Ulcer
16%
Prevalence
16%
Stomach Acid
16%
Diagnosis
16%
Liver Cirrhosis
16%
Observational Study
16%
Cytotechnology
11%
Disease
11%
Cholestasis
10%
Fine-Needle Aspiration
9%
Biopsy Technique
9%
Bile
9%
Health Status
8%
Cholangitis
8%
Obstructive Jaundice
8%
Quality of Life
8%
Protein P53
7%
Salmonella Enterica Serovar Typhi
7%
Liver Abscess
7%
Maturity Onset Diabetes of the Young
7%
Barrett Esophagus
7%
Injury
7%
Leukocyte Adherence Inhibition
7%
Achalasia
7%
Myotomy
7%
Congenital Diaphragm Hernia
7%
Diabetic Retinopathy
7%
Liver Pathology
7%
Elderly Patient
7%
Hernia
7%
Pancreas Stone
7%
Liver Injury
7%
Endoscopic Therapy
7%
Acute Kidney Injury
7%
Duodenum Ulcer
7%
Dysplasia
7%
Chronic Pancreatitis
7%
Pseudomembranous Colitis
7%
Protein Expression
7%
Inflammatory Bowel Disease
7%
Telangiectasia
7%
Hereditary Hemorrhagic Telangiectasia
7%
Crohn's Disease
7%
Granuloma
7%
Lactobacillus
7%
Streptococcus mutans
7%
Oral Cavity
7%
Hepatic Encephalopathy
7%
Etrolizumab
7%
Placebo
7%
Maintenance Therapy
7%
Ulcerative Colitis
7%
Hepatobiliary System
7%
Endoscopic Retrograde Cholangiopancreatography
6%
Bleeding
5%
Pancreatitis
5%
Infection
5%
Hepatocellular Carcinoma
5%
Epistaxis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
20%
Liver Cirrhosis
16%
Prevalence
8%
Infection
8%
Acute Kidney Failure
7%
Protein P53
7%
Liver Cell Carcinoma
7%
Liver Hydatid Cyst
7%
Albendazole
7%
Hospital Infection
7%
Dysplasia
7%
Barrett Esophagus
7%
Liver Abscess
7%
Diabetic Retinopathy
7%
Cholangitis
7%
Salmonella Enterica Serovar Typhi
7%
Etrolizumab
7%
Ulcerative Colitis
7%
Placebo
7%
Non Insulin Dependent Diabetes Mellitus
7%
Stomach Acid
7%
Disease
5%
Metastasis
5%